Aehr Test Systems filings document material events, operating results, capital actions and governance matters for a semiconductor test and burn-in equipment company. Recent Form 8-K disclosures include quarterly financial-result releases covering revenue, bookings, backlog, cash position and GAAP and non-GAAP earnings measures.
The filing record also includes capital-structure disclosures tied to an at-the-market common stock offering under a Form S-3 registration statement, along with proxy and annual meeting materials. Those governance filings address director elections, shareholder voting results, amendments to the company’s equity incentive and employee stock purchase plans, auditor ratification and executive-compensation matters.
AEHR Technologies reported a Form 144 notice listing proposed sales or transfers tied to compensation vesting and option exercise. The excerpt lists multiple restricted stock vesting events (for example, 1,465 shares on 01/11/2024 and 6,546 shares on 04/14/2024) and a stock option exercise of 3,338 shares on 09/16/2024. The filing names Fidelity Brokerage Services LLC as the broker and indicates NASDAQ as the exchange.
AEHR submitted a Form 144 notice identifying proposed sales of Common Stock sourced from multiple restricted stock vesting events. The filing lists specific vesting dates and share counts (examples: 35,187 vested on 07/14/2022; 10,008 vested on 10/14/2022) and names Fidelity Brokerage Services LLC as the broker.
AEHR filed a Form 144 reporting a proposed sale of 3,500 shares of Common Stock by Fidelity Brokerage Services LLC with an indicated date of 04/10/2026 on NASDAQ. The filing also lists multiple restricted stock vesting events issued by the company: 484 (04/27/2025), 1,159 (07/11/2025), 558 (07/27/2025), 1,157 (10/02/2025) and 142 (10/11/2025).
Aehr Test Systems submitted a Form 144/A reporting the proposed sale of 40,000 shares of Common Stock originally from a Private Placement dated 03/15/2013. The filing lists a table row with the figure 2718978.35 and references NASDAQ with a date 04/09/2026.
AEHR affiliate filed a Form 144 notifying the broker Oppenheimer & Co., Inc. of an intended sale of 30,000 shares of Common Stock, tied to a compensation award dated 11/28/2018. The filing lists an aggregate dollar value of $2,100,000.00 and identifies Nasdaq as the market. The filer, Rhea J Posedel, reported prior sales of 13,998 shares on 02/13/2026 for $390,404.22.
Charles Schwab Corp. filed a Form 144 reporting a proposed sale of Common stock. The notice lists 32,762 shares and an aggregate value of $2,164,585.00, with a Nasdaq listing and a filing date of 04/09/2026.
AEHR submitted a Rule 144 notice regarding transfers of Common stock linked to vested RSUs. The excerpt lists multiple vested RSU lots—500 (10/02/2023), 1,500 (04/01/2024), 528 (10/01/2024) and 1,200 (04/03/2023)—and includes an entry showing 247800.00 and 04/09/2026 with Nasdaq referenced.
AEHR Technology submitted a Form 144 notifying of a proposed sale of 10,582 shares related to an option granted on 04/06/2022, with the sale method listed as Cash on 04/09/2026. The filing also lists multiple prior restricted stock vesting events (234; 233; 254; 691; 254; 612; 225 shares) with their respective dates.
Charles Schwab & Co., Inc. notice of proposed sale: 7,665 Restricted Stock Units are listed for sale under Rule 144.
Reporting person Laura Ann Oliphant shows a prior sale of 4,546 shares on 01/22/2026 with proceeds of $142,717.73. The filing lists broker/record details and identifies the securities as Equity Compensation.